ArticleTrials2024

Early tirofiban versus heparin for bridging dual antiplatelet therapy in patients undergoing coronary endarterectomy combined with coronary artery bypass grafting: a multicenter randomized controlled trial protocol (the THACE-CABG trial).

Liang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.